Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease.

Itoh N.

Cell Tissue Res. 2010 Oct;342(1):1-11. doi: 10.1007/s00441-010-1024-2. Epub 2010 Aug 24. Review.

2.

Long-term inactivation particle for voltage-gated sodium channels.

Dover K, Solinas S, D'Angelo E, Goldfarb M.

J Physiol. 2010 Oct 1;588(Pt 19):3695-711. doi: 10.1113/jphysiol.2010.192559. Epub 2010 Aug 2. Erratum in: J Physiol. 2011 Mar 15;589(Pt 6):1505.

3.

Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride.

Li H, Fang Q, Gao F, Fan J, Zhou J, Wang X, Zhang H, Pan X, Bao Y, Xiang K, Xu A, Jia W.

J Hepatol. 2010 Nov;53(5):934-40. doi: 10.1016/j.jhep.2010.05.018. Epub 2010 Jul 17.

PMID:
20675007
4.

Research resource: Comprehensive expression atlas of the fibroblast growth factor system in adult mouse.

Fon Tacer K, Bookout AL, Ding X, Kurosu H, John GB, Wang L, Goetz R, Mohammadi M, Kuro-o M, Mangelsdorf DJ, Kliewer SA.

Mol Endocrinol. 2010 Oct;24(10):2050-64. doi: 10.1210/me.2010-0142. Epub 2010 Jul 28.

5.

Pathways of unconventional protein secretion.

Nickel W.

Curr Opin Biotechnol. 2010 Oct;21(5):621-6. doi: 10.1016/j.copbio.2010.06.004. Epub 2010 Jul 14. Review.

PMID:
20637599
6.

Embryonic survival and severity of cardiac and craniofacial defects are affected by genetic background in fibroblast growth factor-16 null mice.

Lu SY, Jin Y, Li X, Sheppard P, Bock ME, Sheikh F, Duckworth ML, Cattini PA.

DNA Cell Biol. 2010 Aug;29(8):407-15. doi: 10.1089/dna.2010.1024.

PMID:
20618076
7.

FGF receptors 1 and 2 control chemically induced injury and compound detoxification in regenerating livers of mice.

Böhm F, Speicher T, Hellerbrand C, Dickson C, Partanen JM, Ornitz DM, Werner S.

Gastroenterology. 2010 Oct;139(4):1385-96. doi: 10.1053/j.gastro.2010.06.069. Epub 2010 Aug 7.

8.

Distinct FGFs promote differentiation of excitatory and inhibitory synapses.

Terauchi A, Johnson-Venkatesh EM, Toth AB, Javed D, Sutton MA, Umemori H.

Nature. 2010 Jun 10;465(7299):783-7. doi: 10.1038/nature09041. Epub 2010 May 26.

9.

Nonsense mutations in FGF8 gene causing different degrees of human gonadotropin-releasing deficiency.

Trarbach EB, Abreu AP, Silveira LF, Garmes HM, Baptista MT, Teles MG, Costa EM, Mohammadi M, Pitteloud N, Mendonca BB, Latronico AC.

J Clin Endocrinol Metab. 2010 Jul;95(7):3491-6. doi: 10.1210/jc.2010-0176. Epub 2010 May 12. Erratum in: J Clin Endocrinol Metab. 2011 Aug;96(8):2624.

10.

FGF signalling in prostate development, tissue homoeostasis and tumorigenesis.

Lin Y, Wang F.

Biosci Rep. 2010 Apr 9;30(5):285-91. doi: 10.1042/BSR20100020. Review.

PMID:
20406196
11.

Autocrine/paracrine action of vitamin D on FGF23 expression in cultured rat osteoblasts.

Tang WJ, Wang LF, Xu XY, Zhou Y, Jin WF, Wang HF, Gao J.

Calcif Tissue Int. 2010 May;86(5):404-10. doi: 10.1007/s00223-010-9355-2. Epub 2010 Mar 31.

PMID:
20354682
12.

Fibroblast growth factor receptors 1 and 2 in keratinocytes control the epidermal barrier and cutaneous homeostasis.

Yang J, Meyer M, Müller AK, Böhm F, Grose R, Dauwalder T, Verrey F, Kopf M, Partanen J, Bloch W, Ornitz DM, Werner S.

J Cell Biol. 2010 Mar 22;188(6):935-52. doi: 10.1083/jcb.200910126.

13.

The heterohexameric complex structure, a component in the non-classical pathway for fibroblast growth factor 1 (FGF1) secretion.

Mohan SK, Rani SG, Yu C.

J Biol Chem. 2010 May 14;285(20):15464-75. doi: 10.1074/jbc.M109.066357. Epub 2010 Mar 10.

14.

Fibroblast growth factor signalling: from development to cancer.

Turner N, Grose R.

Nat Rev Cancer. 2010 Feb;10(2):116-29. doi: 10.1038/nrc2780. Review.

PMID:
20094046
15.

The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance.

Schreuder TC, Marsman HA, Lenicek M, van Werven JR, Nederveen AJ, Jansen PL, Schaap FG.

Am J Physiol Gastrointest Liver Physiol. 2010 Mar;298(3):G440-5. doi: 10.1152/ajpgi.00322.2009. Epub 2010 Jan 21.

16.

Relevant use of Klotho in FGF19 subfamily signaling system in vivo.

Tomiyama K, Maeda R, Urakawa I, Yamazaki Y, Tanaka T, Ito S, Nabeshima Y, Tomita T, Odori S, Hosoda K, Nakao K, Imura A, Nabeshima Y.

Proc Natl Acad Sci U S A. 2010 Jan 26;107(4):1666-71. doi: 10.1073/pnas.0913986107. Epub 2010 Jan 8.

17.

Modulation of Fgf3 dosage in mouse and men mirrors evolution of mammalian dentition.

Charles C, Lazzari V, Tafforeau P, Schimmang T, Tekin M, Klein O, Viriot L.

Proc Natl Acad Sci U S A. 2009 Dec 29;106(52):22364-8. doi: 10.1073/pnas.0910086106. Epub 2009 Dec 15.

18.

Fibroblast growth factor 19 serum levels: relation to renal function and metabolic parameters.

Reiche M, Bachmann A, Lössner U, Blüher M, Stumvoll M, Fasshauer M.

Horm Metab Res. 2010 Mar;42(3):178-81. doi: 10.1055/s-0029-1243249. Epub 2009 Dec 14.

PMID:
20013647
19.

The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis.

Razzaque MS.

Nat Rev Endocrinol. 2009 Nov;5(11):611-9. doi: 10.1038/nrendo.2009.196. Review.

20.

Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis.

Badman MK, Koester A, Flier JS, Kharitonenkov A, Maratos-Flier E.

Endocrinology. 2009 Nov;150(11):4931-40. doi: 10.1210/en.2009-0532. Epub 2009 Oct 9.

Supplemental Content

Support Center